What Treace Medical Concepts, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 3 | 12 |
| Sells | 0 | 0 |
| Total trades | 7 | 47 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 55,944 | 2,050,208 |
| Disposed | 88,626 | 204,885 |
| Net activity | −32,682 | +1,845,323 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Elder Scot Michael | Chief Legl & Comp Off, CorpSec | Sep 30 | Withheld — tax / exercise cost · F | −25,457 | — | — | 753,226 |
| Treace John T. | Chief Executive Officer | Aug 24 | Open-market buy · P | +11,000 | $4.34 | +$47.7K | 7,404,383 |
| Treace John T. | Chief Executive Officer | Aug 21 | Open-market buy · P | +5,000 | $4.35 | +$21.7K | 7,393,383 |
| Treace John T. | Chief Executive Officer | Aug 20 | Open-market buy · P | +39,944 | $4.44 | +$177K | 7,388,383 |
| Hair Mark | Chief Financial Officer | Aug 09 | Withheld — tax / exercise cost · F | −37,102 | — | — | 914,900 |
| Scanlan Sean F. | Chief Innovation Officer | Aug 09 | Withheld — tax / exercise cost · F | −9,814 | — | — | 679,863 |
| Elder Scot Michael | Chief Legl & Comp Off, CorpSec | Aug 09 | Withheld — tax / exercise cost · F | −16,253 | — | — | 778,683 |
| Treace John T. | Chief Executive Officer | Jun 11 | Open-market buy · P | +9,891 | $4.04 | +$40K | 7,348,439 |
| Treace John T. | Chief Executive Officer | Jun 10 | Open-market buy · P | +14,715 | $4.02 | +$59.2K | 7,338,548 |
| Treace John T. | Chief Executive Officer | Jun 01 | Open-market buy · P | +50,000 | $3.56 | +$178K | 7,323,833 |
| Treace John T. | Chief Executive Officer | May 28 | Open-market buy · P | +61,202 | $3.02 | +$185K | 7,273,833 |
| Treace John T. | Chief Executive Officer | May 27 | Open-market buy · P | +49,810 | $2.87 | +$143K | 7,212,631 |
| Treace John T. | Chief Executive Officer | May 26 | Open-market buy · P | +4,508 | $2.79 | +$12.6K | 7,162,821 |
| Hanna Betsy | Director | May 19 | Grant / award · A | +30,000 | — | — | 75,243 |
| Hamilton Lawrence W | Director | May 19 | Grant / award · A | +30,000 | — | — | 74,056 |
| Jain Deepti | Director | May 19 | Grant / award · A | +30,000 | — | — | 100,243 |
| Berry Lance A | Director | May 19 | Grant / award · A | +30,000 | — | — | 74,593 |
| Kiernan Jane E | Director | May 19 | Grant / award · A | +30,000 | — | — | 93,949 |
| Bakewell John K | Director | May 19 | Grant / award · A | +30,000 | — | — | 204,056 |
| Treace John T. | Chief Executive Officer | May 14 | Open-market buy · P | +61,750 | $2.62 | +$161K | 7,158,313 |
Loading...
